• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致密沉积物病良性亚型的特征:与该疾病进展型的比较。

Characteristics of a benign subtype of dense deposit disease: comparison with the progressive form of this disease.

作者信息

Klein M, Poucell S, Arbus G S, McGraw M, Rance C P, Yoon S J, Baumal R

出版信息

Clin Nephrol. 1983 Oct;20(4):163-71.

PMID:6556977
Abstract

Pathologic, clinical and serum complement studies were performed on 18 patients with dense deposit disease (DDD). The patients were divided into 3 groups: group A (10 patients who developed end-stage renal failure within 2.9 +/- 1.0 years of onset) group B (3 patients who developed elevated serum creatinines within 6.8 +/- 4.8 years of onset) and group C (5 patients with no evidence of renal insufficiency after 11.0 +/- 1.4 years of follow-up). Renal biopsies from all patients showed intramembranous, electron-dense deposits in glomerular capillary basement membranes. Most group A and B patients presented with a nephritic and/or nephrotic syndrome and followed an active clinical course. In contrast, group C patients presented with either a nephrotic syndrome or asymptomatic proteinuria +/- hematuria and followed a benign course. Sera from group A and B patients contained reduced concentrations of C3 and factor B and large amounts of C3 nephritic factor (NeF) activity. In contrast, serum of group C patients contained normal amounts of C3 and factor B and low levels of C3 NeF activity. These studies show that some patients with DDD (group C) have a benign illness and that they can be identified by serum levels of C3, factor B and C3 NeF activity.

摘要

对18例致密沉积物病(DDD)患者进行了病理、临床和血清补体研究。患者分为3组:A组(10例在发病后2.9±1.0年内发展为终末期肾衰竭的患者)、B组(3例在发病后6.8±4.8年内血清肌酐升高的患者)和C组(5例在随访11.0±1.4年后无肾功能不全证据的患者)。所有患者的肾活检均显示肾小球毛细血管基底膜内有膜内电子致密沉积物。大多数A组和B组患者表现为肾炎和/或肾病综合征,临床病程呈活动期。相比之下,C组患者表现为肾病综合征或无症状蛋白尿±血尿,病程呈良性。A组和B组患者的血清中C3和B因子浓度降低,且有大量C3肾炎因子(NeF)活性。相比之下,C组患者的血清中C3和B因子含量正常,C3 NeF活性水平较低。这些研究表明,一些DDD患者(C组)病情良性,可通过血清C3、B因子和C3 NeF活性水平进行识别。

相似文献

1
Characteristics of a benign subtype of dense deposit disease: comparison with the progressive form of this disease.致密沉积物病良性亚型的特征:与该疾病进展型的比较。
Clin Nephrol. 1983 Oct;20(4):163-71.
2
Mesangial proliferative glomerulonephritis with unusual intramembranous granular dense deposits.伴有不寻常的膜内颗粒状致密沉积物的系膜增生性肾小球肾炎
Clin Nephrol. 1983 Feb;19(2):92-8.
3
Heterogeneous histologic and clinical evolution in 3 cases of dense deposit disease with long-term follow-up.3例致密物沉积病的长期随访中组织学和临床的异质性演变
Hum Pathol. 2014 Nov;45(11):2326-33. doi: 10.1016/j.humpath.2014.07.021. Epub 2014 Aug 16.
4
Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children.儿童膜增生性肾小球肾炎(I型)和致密物沉积病(DDD)
Clin Nephrol. 1978 May;9(5):184-93.
5
[Partial lipodystrophy and membranoproliferative glomerulonephritis. Apropos of a case].[部分性脂肪营养不良与膜增生性肾小球肾炎。附病例报告]
An Esp Pediatr. 1989 Jun;30(6):499-502.
6
Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.C3肾小球病的临床病理谱——一项来自印度的经验
Diagn Pathol. 2015 Mar 17;10:6. doi: 10.1186/s13000-015-0233-0.
7
[Complement and nephritic activity in membranoproliferative glomerulonephritis].[膜增生性肾小球肾炎中的补体与肾炎活性]
Arch Fr Pediatr. 1979 Nov;36(9 Suppl):LXIV-LXXIV.
8
[Prognosis of nephrosis].[肾病的预后]
Bol Med Hosp Infant Mex. 1981 May-Jun;38(3):447-55.
9
Dense deposit disease with rapidly progressive renal failure in a narcotic addict.一名麻醉品成瘾者患致密物沉积病并伴有快速进展性肾衰竭。
Clin Nephrol. 1980 Dec;14(6):309-12.
10
Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.葡萄球菌性心内膜炎肾小球肾炎中的新型C3肾炎因子活性
Q J Med. 1987 Nov;65(247):895-8.

引用本文的文献

1
Overactivity of Alternative Pathway Convertases in Patients With Complement-Mediated Renal Diseases.补体介导的肾脏疾病患者旁路途径转化酶的过度活跃。
Front Immunol. 2018 Apr 4;9:612. doi: 10.3389/fimmu.2018.00612. eCollection 2018.
2
Dense deposit disease and C3 glomerulopathy.致密物沉积病和 C3 肾小球病。
Semin Nephrol. 2013 Nov;33(6):493-507. doi: 10.1016/j.semnephrol.2013.08.002.
3
Causes of alternative pathway dysregulation in dense deposit disease.致密物沉积病中旁路途径调控异常的原因。
Clin J Am Soc Nephrol. 2012 Feb;7(2):265-74. doi: 10.2215/CJN.07900811. Epub 2012 Jan 5.
4
A case of regression of atypical dense deposit disease without C3 deposition in a child.一例儿童非典型致密物沉积病无C3沉积且病情消退的病例。
Korean J Pediatr. 2010 Jul;53(7):766-9. doi: 10.3345/kjp.2010.53.7.766. Epub 2010 Jul 31.
5
Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients.致密物沉积病:32例儿童及成人患者的临床病理研究
Clin J Am Soc Nephrol. 2009 Jan;4(1):22-32. doi: 10.2215/CJN.03480708. Epub 2008 Oct 29.
6
Dense deposit disease and the factor H H402 allele.致密沉积物病与补体因子H H402等位基因
Clin Exp Nephrol. 2008 Jun;12(3):228-32. doi: 10.1007/s10157-008-0031-z. Epub 2008 Jan 26.